RAD IMMUNE Trademark

Trademark Overview

On Friday, March 18, 2016, a trademark application was filed for RAD IMMUNE with the United States Patent and Trademark Office. The USPTO has given the RAD IMMUNE trademark a serial number of 86945197. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 18, 2025. This trademark is owned by Rad Immune Inc.. The RAD IMMUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services, namely, clinical and drug development
rad immune

General Information

Serial Number86945197
Word MarkRAD IMMUNE
Filing DateFriday, March 18, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 18, 2025
Registration Number5577470
Registration DateTuesday, October 2, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical drug development services, namely, clinical and drug development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 18, 2025
Primary Code042
First Use Anywhere DateMonday, August 3, 2015
First Use In Commerce DateMonday, August 3, 2015

Trademark Owner History

Party NameRad Immune Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressManhattan Beach, CA 90266
Party NameRad Immune Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressManhattan Beach, CA 90266

Trademark Events

Event DateEvent Description
Wednesday, June 29, 2016NON-FINAL ACTION E-MAILED
Tuesday, March 22, 2016NEW APPLICATION ENTERED
Wednesday, March 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 28, 2016ASSIGNED TO EXAMINER
Wednesday, June 29, 2016NON-FINAL ACTION WRITTEN
Wednesday, June 29, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 21, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 22, 2017FINAL REFUSAL WRITTEN
Wednesday, February 22, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 22, 2017FINAL REFUSAL E-MAILED
Tuesday, August 29, 2017TEAS PETITION TO REVIVE RECEIVED
Tuesday, August 29, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 5, 2017ASSIGNED TO PETITION STAFF
Wednesday, October 11, 2017PETITION GRANTED - RESPONSE RECEIVED
Wednesday, October 11, 2017ASSIGNED TO LIE
Wednesday, October 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 11, 2017NOTICE OF REVIVAL - E-MAILED
Saturday, November 25, 2017SUBSEQUENT FINAL REFUSAL WRITTEN
Saturday, November 25, 2017SUBSEQUENT FINAL EMAILED
Saturday, November 25, 2017NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, May 21, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, May 21, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 20, 2018ASSIGNED TO LIE
Monday, August 27, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 2, 2018REGISTERED-SUPPLEMENTAL REGISTER
Friday, December 21, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 2, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 18, 2025CANCELLED SEC. 8 (6-YR)
Tuesday, August 14, 2018APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Related Keywords

immune drug development clinical namely services pharmaceutical